Sternoclavicular joint injections and their predictive value for the outcome of surgery

Sternoclavicular joint injections are one of the first-line treatment options for painful non-infectious pathologies of the sternoclavicular joint; however, their long-term effects and predictive value in decision-making for surgery are yet to be defined.

27/32 Patients who received in total 36 computed tomography-guided sternoclavicular joint injections in 2012-2017 replied the questionnaire with a mean follow-up of 38 months after the first sternoclavicular joint injection. Of those patients, seven underwent subsequent surgery. We evaluated pain response after sternoclavicular joint injection and American Shoulder and Elbow Surgeons-score at later follow-up.

Directly after sternoclavicular joint injection, pain decreased from Visual Analog Scale 5.3 ± 2.4 to 3.8 ± 3 (p = 0.001). In the seven patients who underwent surgery for degenerative changes, definitive outcome correlated with pain relief after the last infiltration (r = 0.86, p = 0.012). Also, the final American Shoulder and Elbow Surgeons-score was lower in patients with multiple injections compared to those who were satisfied after the first injection (p = 0.019).

Sternoclavicular injections are a useful tool in the context of degenerative sternoclavicular joint disorders as the amount of pain reduction is, in case the short-term effect is not long-lasting, at least a strong indicator for the future success of operative treatment.